Corpus overview


Overview

MeSH Disease

Human Phenotype

Transmission

There are no transmission terms in the subcorpus


Seroprevalence

There are no seroprevalence terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page




    A Single-Center Retrospective and Descriptive Study of Hepatobiliary and Pancreatic MESHD Surgical Oncology during the COVID-19 Epidemic

    Authors: Zhi-Ming Zhao; Xiu-Ping Zhang; Shuai Xu; Xiang-Long Tan; Xuan Zhang; Ming-Gen Hu; Cheng-Gang Li; Yuan-Xing Gao; Guo-Dong Zhao; Rong Liu

    doi:10.21203/rs.3.rs-40427/v1 Date: 2020-07-06 Source: ResearchSquare

    Objective: In the battle against COVID-19, most medical resources in China have been directed to infected MESHD patients in Wuhan. Thus, patients with hepatobiliary pancreatic tumors MESHD who are not suffering from COVID-19 are often not given timely and effective anti- cancer MESHD treatments. In this study, we aimed to describe clinical characteristics, treatment, and outcomes of patients with hepatobiliary and pancreatic MESHD oncology from our department, which retained normal working during the COVID-19 epidemic. We also sought to formulate a set of standardized hospitalization and treatment processes.Methods: A retrospective and descriptive study was conducted involving patients hospitalized from February 1, 2020, to February 29, 2020 (Return to work after the Spring Festival), at our Department of Hepatobiliary and Pancreatic MESHD Surgical Oncology. Results: The study included 92 patients from 12 provinces in the north of China who underwent surgical resection at our Department of Hepatobiliary and Pancreatic MESHD Surgical Oncology during the COVID-19 epidemic. Robotic surgery was performed on 82% (75/92) of patients, while the rest underwent laparoscopic (2/92) and open surgery (15/92). Eighty-six patients had malignant tumor MESHD, and six had emergency benign diseases. Only five patients had severe pancreatic fistula HP pancreatic fistula MESHD, and three had biliary fistula MESHD after operation. Conclusions: The standardized hospitalization and treatment processes described in this study could prevent cross-infection MESHD of patients and still ensure timely treatment of patients with hepatobiliary and pancreatic cancers MESHD. These study findings will guide the management of surgical oncology departments and treatment of patients with hepatobiliary and pancreatic MESHD oncology during serious epidemics.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from Preprints.org and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.

Sources


Annotations

All
None
MeSH Disease
Human Phenotype
Transmission
Seroprevalence


Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.